NCT05694715
- Conditions
- ATM Gene Mutation, BRCA1 Mutation, BRCA2 Mutation, +7 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
PALB2 Gene Mutation
Explore clinical trials studying PALB2 Gene Mutation. Study availability and eligibility vary by location and protocol.
11 public trials
5 recruiting studies
PALB2 Gene Mutation trial results
Recruiting
Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors
NCT06177171
- Conditions
- ATM Gene Mutation, BRCA Mutation, BRCA1 Mutation, +3 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Recruiting
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT04150042
- Conditions
- Adenocarcinoma of the Breast, BRCA1 Mutation, BRCA2 Mutation, +35 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT05097274
- Conditions
- ATM Gene Mutation, BRCA Mutation, CHEK2 Gene Mutation, +14 more
- Locations
-
- Cancer Genetics Unit, Royal Marsden Hospital London, Sutton, Surrey, United Kingdom
- Conditions
- APC Gene Mutation, ATM Gene Mutation, BARD1 Gene Mutation, +19 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activity) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT03377556
- Conditions
- ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation, +18 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer
NCT06783140
- Conditions
- BRCA1/2 Mutation, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, Not Recruiting
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes
NCT02286687
- Conditions
- ATM Gene Mutation, Advanced Malignant Neoplasm, BRCA1 Gene Mutation, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
NCT05692596
- Conditions
- Ataxia, Ataxia Telangiectasia, BRCA Mutation, +62 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Olaparib In Metastatic Breast Cancer
NCT03344965
- Conditions
- ATM Gene Mutation, BRIP1 Gene Mutation, Breast Diseases, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Chicago, Illinois, United States
- Indiana University Indianapolis, Indiana, United States